Investigation of the therapeutic benefit of phytocannabinoids and Cannabis extracts in Alzheimer’s disease using a novel 3D in vitro model.

By the legalization of recreational cannabis in Canada in 2018 and continuing the legal use of medicinal cannabis, there is an emerging need for investigating the health aspect of cannabis products. Despite the memory difficulties that may cause by the long-term use of cannabis some research indicated the benefit of cannabinoids, the bioactive components of […]

Read More
Discovery of Endocannabinoid modulating compounds for Alzheimer’s disease therapeutics development

Alzheimer’s is the most common form of dementia which worsens over time. Current therapeutic against Alzheimer’s disease provides only symptomatic treatment. This limited effectiveness provides us with an opportunity to direct our research efforts towards developing new agents to prevent or retard the disease. Studies have shown that very small amount of tetrahydrocannabinol (THC), a […]

Read More
The effect of phyto-cannabinoids on osteoclast differentiation and function

The recent legalization of marijuana in Canada opens the opportunity to study in detail the effects of cannabinoids on human physiology. This academic-industry initiative will combine resources to isolate compounds from cannabinoids to study their effects on bone cells. Specifically it will examine the effects of cannabinoid compounds on how the destructive osteoclasts form and […]

Read More